Osteonecrosis in human immunodeficiency virus (HIV)-infected patients: A multicentric case-control study

Journal of Bone and Mineral Metabolism

Volumn 29, Issue 3, 2011, Pages 383-388

  Mazzotta, Elena ^a   Agostinone, Adriana ^a   Rosso, Raffaella ^b   Di Biagio, Antonio ^b   De Socio, Giuseppe Vittorio ^c   Cappelletti, Anna ^d   Zicolella, Raffaele ^a   Polilli, Ennio ^e   Bonfanti, Paolo ^f   Di Matteo, Luigi ^a   Manzoli, Lamberto ^g   Parruti, Giustino ^a  

^a SPIRITO SANTO HOSPITAL   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^d SANT ANNA HOSPITAL   (Italy)

^e Pescara General Hospital   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

^g UNIVERSITY OF CHIETI   (Italy)

Author keywords

Dyslipidemia; HIV; IgE; Loss of working ability; Osteonecrosis

Indexed keywords

ANTIRETROVIRUS AGENT; CHOLESTEROL; IMMUNOGLOBULIN E; STEROID; TRIACYLGLYCEROL;

ADULT; ANTIBODY TITER; ARTICLE; BONE NECROSIS; CASE CONTROL STUDY; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EXPOSURE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; IMMUNOGLOBULIN BLOOD LEVEL; LONG TERM EXPOSURE; LYMPHOCYTE COUNT; MALE; PREDICTION; PRIORITY JOURNAL; WORK CAPACITY;

ADULT; CASE-CONTROL STUDIES; DEMOGRAPHY; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; OSTEONECROSIS;

EID: 79959967977     PISSN: 09148779     EISSN: 14355604     Source Type: Journal    
DOI: 10.1007/s00774-010-0245-5     Document Type: Article

References (33)

1. -(2009) Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. US Department of Health and Human Services. http://aidsinfo.nih.gov/OrderPublication/OrderPubsBrowseSearchResultsTable.aspx? ID=115. Accessed July 2010
2. D:A:D Study Group, Sabin CA, Worm SW, Weber R, Reiss P, El-Sadr W, Dabis F, De Wit S, Law M, D'Arminio Monforte A, Friis-Møller N, Kirk O, Pradier C, Weller I, Phillips AN, Lundgren JD (2008) Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. Lancet 371:1417-1426
3. Mondy K, Tebas P (2003) Emerging bone problems in patients infected with human immunodeficiency virus. Clin Infect Dis 36:101-105
4. Miller KD, Masur H, Jones EC, Joe GO, Rick ME, Kelly GG, Mican JM, Liu S, Gerber LH, Blackwelder WC, Falloon J, Davey RT, Polis MA, Walker RE, Lane HC, Kovacs JA (2002) High prevalence of osteonecrosis of the femoral head in HIV-infected adults. Ann Intern Med 137:17-25
5. Allison GT, Bostrom MP, Glesby MJ (2003) Osteonecrosis in HIV disease: epidemiology, etiologies, and clinical management. AIDS 17:1-9 (Pubitemid 36106293)
6. Martin K, Lawson-Ayayi S, Miremont-Salamé G, Blaizeau MJ, Balestre E, Lacoste D, Ragnaud JM, Malvy D, Dupon M, Mercié P, Schaeverbeke T, Haramburu F, Dabis F (2004) Symptomatic bone disorders in HIV-infected patients: incidence in the Aquitaine cohort (1999-2000). HIV Med 5:421-426 (Pubitemid 39555456)
7. Mary-Krause M, Billaud E, Poizot-Martin I, Simon A, Dhiver C, Dupont C, Salmon D, Roudiere L, Costagliola D, Clinical Epidemiology Group of the French Hospital Database (2006) Risk factors for osteonecrosis in HIV-infected patients: impact of treatment with combination antiretroviral therapy. AIDS 20:1627-1635 (Pubitemid 44162405)
8. Gutiérrez F, Padilla S, Masiá M, Flores J, Boix V, Merino E, Galindo J, Ortega E, López-Aldeguer J, Galera C (2006) HIV-related Osteonecrosis Study Group Osteonecrosis in patients infected with HIV: clinical epidemiology and natural history in a large case series from Spain. J Acquir Immune Defic Syndr 42:286-292 (Pubitemid 44050005)
9. Morse CG, Mican JM, Jones EC, Joe GO, Rick ME, Formentini E, Kovacs JA (2007) The incidence and natural history of osteonecrosis in HIV-infected adults. Clin Infect Dis 44:739-748
10. Valencia ME, Barreiro P, Soriano V, Blanco F, Moreno V, Lahoz JG (2003) Avascular necrosis in HIV-infected patients receiving antiretroviral treatment: study of seven cases. HIV Clin Trials 4:132-136 (Pubitemid 36410917)
11. Lazzarin P, Cesaro G, Puggina S, Perin B, Cremonini L, Padovani G, Sfriso P, Sartori T (2004) Femoral and humeral head osteonecrosis in a patient with hypofibrinolysis and hyperhomocysteinemia. A case report and a review of the literature. Reumatismo 56:202-210 (Pubitemid 39313009)
12. Scribner AN, Troia-Cancio PV, Cox BA, Marcantonio D, Hamid F, Keiser P, Levi M, Allen B, Murphy K, Jones RE, Skiest DJ (2000) Osteonecrosis in HIV: a case-control study. J Acquir Immune Defic Syndr 25:19-25
13. Glesby MJ, Hoover DR, Vaamonde CM (2001) Osteonecrosis in patients infected with human immunodeficiency virus: a case-control study. J Infect Dis 184:519-523 (Pubitemid 32718519)
14. Khanna AJ, Yoon TR, Mont MA, Hungerford DS, Bluemke DA (2000) Femoral head osteonecrosis: detection and grading by using a rapid MR imaging protocol. Radiology 217:188-192 (Pubitemid 33097600)
15. Kirk JK, Nichols M, Spangler JG (2002) Use of a peripheral dexa measurement for osteoporosis screening. Fam Med 34:201-205 (Pubitemid 34208786)
16. Yang NP, Jen I, Chuang SY, Chen SH, Chou P (2006) Screening for low bone mass with quantitative ultrasonography in a community without dual-energy X-ray absorptiometry: population-based survey. BMC Musculoskelet Disord 7:24-32
17. Ficat RP, Arlet J (1980) Functional investigation of bone under normal conditions. In: Hungenford DS (ed) Ischemia and necrosis of bone. Williams and Wilkins, Baltimore
18. Malizos KN, Karantanas AH, Varitimidis SE, Dailiana ZH, Bargiotas K, Maris T (2007) Osteonecrosis of the femoral head: etiology, imaging and treatment. Eur J Radiol 63:16-28 (Pubitemid 46907479)
19. Wolfe CJ, Taylor-Butler KL (2000) Avascular necrosis. A case history and literature review. Arch Fam Med 9:291-294
20. Patella V, Florio G, Petraroli A, Marone G (2000) HIV-1 gp120 induces IL-4 and IL-13 release from human Fc epsilon RI+ cells through interaction with the VH3 region of IgE. J Immunol 164:589-595 (Pubitemid 30043677)
21. Marone G, Florio G, Triggiani M, Petraroli A, de Paulis A (2000) Mechanisms of IgE elevation in HIV-1 infection. Crit Rev Immunol 20:477-496 (Pubitemid 32496680)
22. Takekawa H, Miyamoto K, Yamaguchi E, Munakata M, Kawakami Y (1993) Acute rise in serum immunoglobulin E concentration in pulmonary thromboembolism. Chest 104:61-64 (Pubitemid 23204529)
23. Kovanen PT, Mänttäri M, Palosuo T, Manninen V, Aho K (1988) Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M. Arch Intern Med 158:1434-1439
24. Sinkiewicz W, Błazejewski J, Bujak R, Kubica J, Dudziak J (2008) Immunoglobulin E in patients with ischemic heart disease. Cardiol J 15:122-128 (Pubitemid 351721973)
25. Edston E, van Hage-Hamsten M (1995) Immunoglobulin E, mast cell-specific tryptase and the complement system in sudden death from coronary artery thrombosis. Int J Cardiol 52:77-81
26. Szczeklik A, Dropiński J, Góra PF (1993) Serum immunoglobulin E and sudden cardiac arrest during myocardial infarction. Coron Artery Dis 4:1029-1032 (Pubitemid 24021142)
27. Langer RD, Criqui MH, Feigelson HS, McCann TJ, Hamburger RN (1996) IgE predicts future nonfatal myocardial infarction in men. J Clin Epidemiol 49:203-209 (Pubitemid 26123931)
28. Korkmaz ME, Oto A, Saraçlar Y, Oram E, Oram A, Ugurlu S, Karamehmetoglu A, Karaagaoglu E (1991) Levels of IgE in the serum of patients with coronary arterial disease. Int J Cardiol 31:199-204
29. Pitchford SC (2007) Defining a role for platelets in allergic inflammation. Biochem Soc Trans 35:1104-1108 (Pubitemid 350206439)
30. Janiszewski PM, Ross R (2009) The utility of physical activity in the management of global cardiometabolic risk. Obesity (Silver Spring) 17:S3-S14
31. Goldstein LB, Adams R, Alberts MJ et al.; American Heart Association/American Stroke Association Stroke Council; Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; Quality of Care and Outcomes Research Interdisciplinary Working Group; American Academy of Neurology (2006) Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke 37:1583-1633
32. Jiang B, Hebert VY, Li Y, Mathis JM, Alexander JS, Dugas TR (2007) HIV antiretroviral drug combination induces endothelial mitochondrial dysfunction and reactive oxygen species production, but not apoptosis. Toxicol Appl Pharmacol 224:60-71 (Pubitemid 47404622)
33. Wolf K, Tsakiris DA, Weber R, Erb P, Battegay M, Swiss HIV Cohort Study (2002) Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1. J Infect Dis 185:456-462 (Pubitemid 34142807)